SKI Market

Indian Indices

Nifty

25,959.50 -108.65
(-0.42%)

Sensex

85,025.95 125.24
( 0.15%)

Bank Nifty

58,835.35 -32.35
( -0.05%)

Nifty IT

37,037.95 152.60
( 0.41%)

Global Indices

Nasdaq

46,469.70 203.28
(0.44%)

Dow Jones

6,726.36 102.37
(1.55%)

Hang Seng

48,653.14 -1,170.80
(-2.35%)

Nikkei 225

9,569.96 30.25
(0.32%)

Forex

USD-INR

89.60 0.93
(1.05%)

EUR-INR

103.15 0.96
(0.94%)

GBP-INR

117.32 1.44
(1.24%)

JPY-INR

0.57 0.01
(1.69%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Par Drugs & Chemicals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

535341

INE04LG01015

86.4979964

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PAR

11.64

112.71

EPS(TTM)

Face Value()

Div & Yield %

7.87

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	113.39	107.26	95.75	84.85	69.07	55.84
Excise Duty	12.42	11.62	0.00	9.78	8.32	0.00
Net Sales	100.97	95.64	95.75	75.07	60.75	55.84
Other Income	2.15	0.24	0.24	0.18	2.18	0.10
Stock Adjustments	1.28	-0.47	0.70	0.79	0.21	-1.46
Total Income	104.40	95.41	96.69	76.04	63.14	54.48
EXPENDITURE :
Raw Materials	39.41	33.32	41.03	29.61	22.09	22.19
Power & Fuel Cost	19.49	16.40	17.83	13.49	9.82	10.70
Employee Cost	5.85	5.50	4.89	4.10	3.98	4.11
Other Manufacturing Expenses	6.01	5.57	4.68	4.02	3.43	3.16
Selling & Administrative Expenses	11.63	10.16	9.60	8.22	5.62	4.58
Miscellaneous Expenses	0.36	1.40	0.22	0.16	0.01	0.18
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	82.75	72.35	78.25	59.61	44.95	44.93
Operating Profit	21.65	23.06	18.44	16.43	18.19	9.54
Interest	0.08	0.11	0.13	0.45	0.64	0.79
Gross Profit	21.57	22.95	18.31	15.98	17.55	8.75
Depreciation	3.65	3.44	3.23	3.28	2.82	2.76
Profit Before Tax	17.92	19.51	15.08	12.70	14.73	5.99
Tax	4.53	4.98	3.80	3.35	3.36	1.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.04	0.04	-0.05	0.14	-0.25	0.23
Reported Net Profit	13.36	14.50	11.33	9.21	11.61	4.76
Extraordinary Items	0.79	0.01	0.11	0.00	1.53	0.02
Adjusted Net Profit	12.57	14.49	11.22	9.21	10.08	4.74
Adjustment below Net Profit	-0.02	-0.11	0.03	-0.01	-0.01	-0.01
P & L Balance brought forward	62.55	48.16	36.80	29.13	17.53	14.48
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	1.54	0.00	1.70
P & L Balance carried down	75.89	62.55	48.16	36.80	29.13	17.53
Dividend	0.00	0.00	0.00	1.54	0.00	1.54
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	25.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	2.50
Earnings Per Share-Unit Curr	10.86	11.79	9.21	7.49	18.87	7.75
Earnings Per Share(Adj)-Unit Curr	10.86	11.79	9.21	7.49	9.44	3.88
Book Value-Unit Curr	80.44	69.59	57.90	48.66	84.87	66.02
Book Value(Adj)-Unit Curr	80.44	69.59	57.90	48.66	42.44	33.01

25,959.50 -108.65 (-0.42%)

85,025.95 125.24 ( 0.15%)

58,835.35 -32.35 ( -0.05%)

37,037.95 152.60 ( 0.41%)

46,469.70 203.28 (0.44%)

6,726.36 102.37 (1.55%)

48,653.14 -1,170.80 (-2.35%)

9,569.96 30.25 (0.32%)

89.60 0.93 (1.05%)

103.15 0.96 (0.94%)

117.32 1.44 (1.24%)

0.57 0.01 (1.69%)